Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Mar 26, 2018
Director
Director Other acquisition or disposition -- --
Mar 26, 2018
Director
Director Other acquisition or disposition -- --
Mar 26, 2018
Director
Director Other acquisition or disposition -- --
Mar 26, 2018
Director
Director Open market or private sale of non-derivative or derivative security 30,000 $17.34
Mar 22, 2018
EVP & Chief Financial Officer
EVP & Chief Financial Officer Other acquisition or disposition -- --
Mar 22, 2018
EVP & Chief Financial Officer
EVP & Chief Financial Officer Open market or private sale of non-derivative or derivative security 2,640 $18.13
Mar 22, 2018
Director, CEO & President
Director, CEO & President Open market or private sale of non-derivative or derivative security 3,100 $18.17
Mar 21, 2018
Director
Director Open market or private sale of non-derivative or derivative security 4,200 $18.64
Mar 21, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 30,000 $2.55
Mar 21, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 30,000 --
Mar 09, 2018
Director
Director Other acquisition or disposition -- --
Mar 09, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 500,000 --
Mar 09, 2018
Director
Director Other acquisition or disposition -- --
Mar 09, 2018
Director
Director Other acquisition or disposition -- --
Mar 09, 2018
Director
Director Other acquisition or disposition -- --
Mar 09, 2018
Director
Director Other acquisition or disposition -- --
Mar 09, 2018
Director
Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 500,000 $2.55
Jan 15, 2018
EVP & Chief Financial Officer
EVP & Chief Financial Officer Other acquisition or disposition -- --
Jan 15, 2018
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 87,500 --
Jan 15, 2018
EVP & Chief Financial Officer
EVP & Chief Financial Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 19,445 --
Jan 15, 2018
Chief Operating Officer
Chief Operating Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Jan 15, 2018
Chief Operating Officer
Chief Operating Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 175,000 --
Jan 15, 2018
Chief Operating Officer
Chief Operating Officer Other acquisition or disposition -- --
Jan 15, 2018
Director
Director Other acquisition or disposition -- --
Jan 15, 2018
Director
Director Other acquisition or disposition -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright Nasdaq. Minimum 15 minutes delayed.